The Patent Finder
US

Treatment Methods Having Reduced Drug-Related Toxicity and Methods of Identifying the Likelihood of Patient Harm from Prescribed Medications

US 12,474,326 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Oct 30, 2026 (Antares Capital LP).

Term ends May 19, 2037 · High confidence

Filed Nov 6, 2023 as application 18/502,543 · Granted Nov 18, 2025
Base term, 20 years from filing
Today
20 years from filing
2017 2037
Clock starts
May 19, 2017
Term ends
May 19, 2037
Granted
Nov 18, 2025
base term Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 19, 2017, when application PCT/US2017/033539, the earliest non-provisional in its chain, was filed (this one was filed Nov 6, 2023)May 19, 2037High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 19, 2037High confidence

This family

Application PCT/US2017/033539PCT application
no patent term
no patent term
US 10,890,577In force
May 2037
May 2037
US 11,808,759In force
May 2037
May 2037
US 12,474,326this patent
May 2037
May 2037
Application 19/367,658Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 28, 2023
Reel 65973, frame 835
Turgeon, Jacques; Steffen, Lauren E.; Badea, Gabriel; Michaud, VeroniqueTabula Rasa Healthcare, Inc.Assignment of Assignor's Interest
Oct 30, 2026
Reel 76583, frame 832
Tabula Rasa Healthcare, Inc.; Tabula Rasa Healthcare Group, Inc.; Exact Care Pharmacy, LLCAntares Capital LP, as Collateral AgentSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited